{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:57:33Z","timestamp":1790686653014,"version":"4.1.0"},"reference-count":105,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Grant-in-Aid for Scientific Research","award":["17K08598"],"award-info":[{"award-number":["17K08598"]}]},{"name":"Grant-in-Aid for Young Scientists","award":["17K15581"],"award-info":[{"award-number":["17K15581"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.bcp.2019.02.020","type":"journal-article","created":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T11:05:16Z","timestamp":1550228716000},"page":"207-213","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Glycogen synthase kinase-3 inhibitor as a multi-targeting anti-rheumatoid drug"],"prefix":"10.1016","volume":"165","author":[{"given":"Masaki","family":"Arioka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumi","family":"Takahashi-Yanaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6937","key":"10.1016\/j.bcp.2019.02.020_b0005","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature01661","article-title":"Evolving concepts of rheumatoid arthritis","volume":"423","author":"Firestein","year":"2003","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bcp.2019.02.020_b0010","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/14397595.2016.1265907","article-title":"Autoimmunity as a trigger for structural bone damage in rheumatoid arthritis","volume":"27","author":"Schett","year":"2017","journal-title":"Mod. Rheumatol."},{"issue":"10","key":"10.1016\/j.bcp.2019.02.020_b0015","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1002\/art.10568","article-title":"Radiographic healing with sustained clinical remission in a patient with rheumatoid arthritis receiving methotrexate monotherapy","volume":"46","author":"Wassenberg","year":"2002","journal-title":"Arthritis Rheum."},{"issue":"10086","key":"10.1016\/j.bcp.2019.02.020_b0020","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1016\/S0140-6736(17)31472-1","article-title":"Pathogenetic insights from the treatment of rheumatoid arthritis","volume":"389","author":"McInnes","year":"2017","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.bcp.2019.02.020_b0025","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1136\/annrheumdis-2016-210708","article-title":"Safety of synthetic and biological DMARDs: a systematic literature review informing the 2016 update of the EULAR recommendations for management of rheumatoid arthritis","volume":"76","author":"Ramiro","year":"2017","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.bcp.2019.02.020_b0030","first-page":"339","article-title":"Multisite phosphorylation of glycogen synthase. Molecular basis for the substrate specificity of glycogen synthase kinase-3 and casein kinase-II (glycogen synthase kinase-5)","volume":"788","author":"Woodgett","year":"1984","journal-title":"BBA"},{"issue":"2","key":"10.1016\/j.bcp.2019.02.020_b0035","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.bcp.2013.04.022","article-title":"Activator or inhibitor? GSK-3 as a new drug target","volume":"86","author":"Takahashi-Yanaga","year":"2013","journal-title":"Biochem. Pharmacol."},{"issue":"11","key":"10.1016\/j.bcp.2019.02.020_b0040","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.2174\/1389450110607011435","article-title":"Role of glycogen synthase kinase-3 in insulin resistance and type 2 diabetes","volume":"7","author":"Henriksen","year":"2006","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.bcp.2019.02.020_b0045","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejmech.2015.10.018","article-title":"Pivotal role of glycogen synthase kinase-3: a therapeutic target for Alzheimer's disease","volume":"107","author":"Maqbool","year":"2016","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bcp.2019.02.020_b0050","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.canlet.2008.05.045","article-title":"Glycogen synthase kinase 3\u03b2 (GSK3\u03b2) in tumorigenesis and cancer chemotherapy","volume":"273","author":"Luo","year":"2009","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.bcp.2019.02.020_b0055","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1161\/CIRCRESAHA.116.303613","article-title":"The GSK-3 family as therapeutic target for myocardial diseases","volume":"116","author":"Lal","year":"2015","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.bcp.2019.02.020_b0060","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1074\/jbc.M406294200","article-title":"Glucocorticoids inhibit the transcriptional activity of LEF\/TCF in differentiating osteoblasts in a glycogen synthase kinase-3\u03b2-dependent and -independent manner","volume":"280","author":"Smith","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.bcp.2019.02.020_b0065","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/iub.187","article-title":"GSK-3: a key player in neurodegeneration and memory","volume":"61","author":"Giese","year":"2009","journal-title":"IUBMB Life"},{"issue":"11","key":"10.1016\/j.bcp.2019.02.020_b0070","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.2174\/1389450110607011421","article-title":"Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions","volume":"7","author":"Jope","year":"2006","journal-title":"Curr. Drug Targets"},{"issue":"4\u20135","key":"10.1016\/j.bcp.2019.02.020_b0075","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s11064-006-9128-5","article-title":"Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics","volume":"32","author":"Jope","year":"2007","journal-title":"Neurochem. Res."},{"issue":"7","key":"10.1016\/j.bcp.2019.02.020_b0080","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1073\/pnas.95.7.3597","article-title":"Osteoclast differentiation factor is a ligand for osteoprotegerin\/osteoclastogenesis-inhibitory factor and is identical to TRANCE\/RANKL","volume":"95","author":"Yasuda","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"2","key":"10.1016\/j.bcp.2019.02.020_b0085","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0002-9440(10)64556-7","article-title":"Osteoprotegerin ligand modulates murine osteoclast survival in vitro and in vivo","volume":"157","author":"Lacey","year":"2000","journal-title":"Am. J. Pathol."},{"issue":"13","key":"10.1016\/j.bcp.2019.02.020_b0090","doi-asserted-by":"crossref","first-page":"9358","DOI":"10.1074\/jbc.C600321200","article-title":"STAT3 regulates cytokine-mediated generation of inflammatory helper T cells","volume":"282","author":"Yang","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"7090","key":"10.1016\/j.bcp.2019.02.020_b0095","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature04754","article-title":"Transforming growth factor-\u03b2 induces development of the TH17 lineage","volume":"441","author":"Mangan","year":"2006","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bcp.2019.02.020_b0100","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.immuni.2006.01.001","article-title":"TGF\u03b2 in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells","volume":"24","author":"Veldhoen","year":"2006","journal-title":"Immunity"},{"issue":"7090","key":"10.1016\/j.bcp.2019.02.020_b0105","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bcp.2019.02.020_b0110","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/art.21537","article-title":"Interleukin-6 modulates production of T lymphocyte-derived cytokines in antigen-induced arthritis and drives inflammation-induced osteoclastogenesis","volume":"54","author":"Wong","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bcp.2019.02.020_b0115","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3389\/fimmu.2012.00077","article-title":"Inflammation and bone destruction in arthritis: synergistic activity of immune and mesenchymal cells in joints","volume":"3","author":"Komatsu","year":"2012","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.bcp.2019.02.020_b0120","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","article-title":"Littman, The orphan nuclear receptor ROR\u03b3t directs the differentiation program of proinflammatory IL-17+ T helper cells","volume":"126","author":"Ivanov","year":"2006","journal-title":"Cell"},{"issue":"7192","key":"10.1016\/j.bcp.2019.02.020_b0125","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/nature06878","article-title":"TGF-\u03b2-induced Foxp3 inhibits TH17 cell differentiation by antagonizing ROR\u03b3t function","volume":"453","author":"Zhou","year":"2008","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.bcp.2019.02.020_b0130","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/ni1261","article-title":"A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17","volume":"6","author":"Park","year":"2005","journal-title":"Nat. Immunol."},{"issue":"9","key":"10.1016\/j.bcp.2019.02.020_b0135","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1056\/NEJMra0707449","article-title":"Interleukin-17 and type 17 helper T cells","volume":"361","author":"Miossec","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"6759","key":"10.1016\/j.bcp.2019.02.020_b0140","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/46303","article-title":"Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand","volume":"402","author":"Kong","year":"1999","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bcp.2019.02.020_b0145","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1006\/bbrc.1999.1623","article-title":"Activated T lymphocytes support osteoclast formation in vitro","volume":"265","author":"Horwood","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"9","key":"10.1016\/j.bcp.2019.02.020_b0150","article-title":"IL-17 cytokines in immunity and inflammation","volume":"2","author":"Jin","year":"2013","journal-title":"Emerg Microbes Infect"},{"issue":"6","key":"10.1016\/j.bcp.2019.02.020_b0155","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.immuni.2018.04.009","article-title":"Autoimmune Th17 cells induced synovial stromal and innate lymphoid cell secretion of the cytokine GM-CSF to initiate and augment autoimmune arthritis","volume":"48","author":"Hirota","year":"2018","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.bcp.2019.02.020_b0160","doi-asserted-by":"crossref","first-page":"5245","DOI":"10.4049\/jimmunol.178.8.5245","article-title":"Granulocyte-macrophage colony-stimulating factor (CSF) and macrophage CSF-dependent macrophage phenotypes display differences in cytokine profiles and transcription factor activities: implications for CSF blockade in inflammation","volume":"178","author":"Fleetwood","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.bcp.2019.02.020_b0165","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s41232-016-0014-5","article-title":"GM-CSF as a therapeutic target in autoimmune diseases","volume":"36","author":"Shiomi","year":"2016","journal-title":"Inflamm Regen"},{"issue":"3","key":"10.1016\/j.bcp.2019.02.020_b0170","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0049-0172(03)00134-3","article-title":"Cyclooxygenase-2 and prostaglandins in articular tissues","volume":"33","author":"Martel-Pelletier","year":"2003","journal-title":"Semin. Arthritis Rheum."},{"issue":"8","key":"10.1016\/j.bcp.2019.02.020_b0175","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1002\/art.22794","article-title":"Prostaglandin E2 exacerbates collagen-induced arthritis in mice through the inflammatory interleukin-23\/interleukin-17 axis","volume":"56","author":"Sheibanie","year":"2007","journal-title":"Arthritis Rheum."},{"issue":"11","key":"10.1016\/j.bcp.2019.02.020_b0180","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.exger.2010.06.007","article-title":"Prostaglandin E2-dependent IL-23 production in aged murine dendritic cells","volume":"45","author":"Myer","year":"2010","journal-title":"Exp. Gerontol."},{"issue":"3","key":"10.1016\/j.bcp.2019.02.020_b0185","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1084\/jem.20082293","article-title":"Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2\/EP4 receptor signaling","volume":"206","author":"Boniface","year":"2009","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.bcp.2019.02.020_b0190","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1365-2567.2006.02376.x","article-title":"E prostanoid 2 (EP2)\/EP4-mediated suppression of antigen-specific human T-cell responses by prostaglandin E2","volume":"118","author":"Okano","year":"2006","journal-title":"Immunology"},{"issue":"6","key":"10.1016\/j.bcp.2019.02.020_b0195","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nm.1968","article-title":"Prostaglandin E2-EP4 signaling promotes immune inflammation through Th1 cell differentiation and Th17 cell expansion","volume":"15","author":"Yao","year":"2009","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.bcp.2019.02.020_b0200","doi-asserted-by":"crossref","DOI":"10.3390\/jcm6090081","article-title":"IL-23 and Th17 disease in inflammatory arthritis","volume":"6","author":"Yago","year":"2017","journal-title":"J. Clin. Med."},{"issue":"12","key":"10.1016\/j.bcp.2019.02.020_b0205","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.1002\/art.20678","article-title":"Expression of toll-like receptors 2 and 4 in rheumatoid synovial tissue and regulation by proinflammatory cytokines interleukin-12 and interleukin-18 via interferon-\u03b3","volume":"50","author":"Radstake","year":"2004","journal-title":"Arthritis Rheum."},{"issue":"7","key":"10.1016\/j.bcp.2019.02.020_b0210","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1002\/art.22707","article-title":"Increased macrophage activation mediated through toll-like receptors in rheumatoid arthritis","volume":"56","author":"Huang","year":"2007","journal-title":"Arthritis Rheum."},{"issue":"11","key":"10.1016\/j.bcp.2019.02.020_b0215","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.molmed.2007.09.002","article-title":"Signaling to NF-\u03baB by toll-like receptors","volume":"13","author":"Kawai","year":"2007","journal-title":"Trends Mol. Med."},{"issue":"12","key":"10.1016\/j.bcp.2019.02.020_b0220","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1084\/jem.20061775","article-title":"Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction","volume":"203","author":"Sato","year":"2006","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.bcp.2019.02.020_b0225","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/art.33390","article-title":"Interleukin-21 promotes osteoclastogenesis in humans with rheumatoid arthritis and in mice with collagen-induced arthritis","volume":"64","author":"Kwok","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.bcp.2019.02.020_b0230","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/art.33446","article-title":"Interleukin-22 promotes osteoclastogenesis in rheumatoid arthritis through induction of RANKL in human synovial fibroblasts","volume":"64","author":"Kim","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.bcp.2019.02.020_b0235","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1136\/ard.59.6.455","article-title":"Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis","volume":"59","author":"Yoshihara","year":"2000","journal-title":"Ann. Rheum. Dis."},{"issue":"10","key":"10.1016\/j.bcp.2019.02.020_b0240","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/nm.2452","article-title":"Evidence for osteocyte regulation of bone homeostasis through RANKL expression","volume":"17","author":"Nakashima","year":"2011","journal-title":"Nat. Med."},{"issue":"10","key":"10.1016\/j.bcp.2019.02.020_b0245","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/nm.2448","article-title":"Matrix-embedded cells control osteoclast formation","volume":"17","author":"Xiong","year":"2011","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.bcp.2019.02.020_b0250","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1172\/JCI5703","article-title":"IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis","volume":"103","author":"Kotake","year":"1999","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.bcp.2019.02.020_b0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061960","article-title":"The Role of Thymosin Beta 4 on odontogenic differentiation in human dental pulp cells","volume":"8","author":"Lee","year":"2013","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.bcp.2019.02.020_b0260","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S8756-3282(99)00162-3","article-title":"Interleukin-1\u03b2 and tumor necrosis factor-alpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells","volume":"25","author":"Hofbauer","year":"1999","journal-title":"Bone"},{"issue":"6","key":"10.1016\/j.bcp.2019.02.020_b0265","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.4049\/jimmunol.169.6.3353","article-title":"IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-\u03baB ligand, osteoprotegerin, and receptor activator of NF-\u03baB in mouse calvariae","volume":"169","author":"Palmqvist","year":"2002","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.bcp.2019.02.020_b0270","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/jbmr.5650110110","article-title":"Prostaglandin E2 stimulates osteoclast-like cell formation and bone-resorbing activity via osteoblasts: role of cAMP-dependent protein kinase","volume":"11","author":"Kaji","year":"1996","journal-title":"J. Bone Miner. Res."},{"issue":"7","key":"10.1016\/j.bcp.2019.02.020_b0275","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3109\/08820139.2013.822766","article-title":"The role of cytokines in inflammatory bone loss","volume":"42","author":"Souza","year":"2013","journal-title":"Immunol. Invest."},{"issue":"9","key":"10.1016\/j.bcp.2019.02.020_b0280","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/art.1780270902","article-title":"Chondroclasts and osteoclasts at subchondral sites of erosion in the rheumatoid joint","volume":"27","author":"Bromley","year":"1984","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.bcp.2019.02.020_b0285","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1084\/jem.191.2.275","article-title":"Tumor necrosis factor \u03b1 stimulates osteoclast differentiation by a mechanism independent of the ODF\/RANKL-RANK interaction","volume":"191","author":"Kobayashi","year":"2000","journal-title":"J. Exp. Med."},{"issue":"7","key":"10.1016\/j.bcp.2019.02.020_b0290","doi-asserted-by":"crossref","first-page":"4858","DOI":"10.1074\/jbc.275.7.4858","article-title":"Tumor necrosis factor-\u03b1 induces differentiation of and bone resorption by osteoclasts","volume":"275","author":"Azuma","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2019.02.020_b0295","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.4049\/jimmunol.0803007","article-title":"The mechanism of osteoclast differentiation induced by IL-1","volume":"183","author":"Kim","year":"2009","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.bcp.2019.02.020_b0300","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1210\/endo.140.4.6647","article-title":"Prostaglandin E2 cooperates with TRANCE in osteoclast induction from hemopoietic precursors: synergistic activation of differentiation, cell spreading, and fusion","volume":"140","author":"Wani","year":"1999","journal-title":"Endocrinology"},{"issue":"12","key":"10.1016\/j.bcp.2019.02.020_b0305","doi-asserted-by":"crossref","first-page":"11395","DOI":"10.1074\/jbc.M411189200","article-title":"Prostaglandin E2 enhances osteoclastic differentiation of precursor cells through protein kinase A-dependent phosphorylation of TAK1","volume":"280","author":"Kobayashi","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.bcp.2019.02.020_b0310","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1084\/jem.20050978","article-title":"Osteoclast differentiation independent of the TRANCE-RANK-TRAF6 axis","volume":"202","author":"Kim","year":"2005","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.bcp.2019.02.020_b0315","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1210\/endo.143.3.8701","article-title":"TNF\u03b1 potently activates osteoclasts, through a direct action independent of and strongly synergistic with RANKL","volume":"143","author":"Fuller","year":"2002","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.bcp.2019.02.020_b0320","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1006\/excr.1998.4320","article-title":"Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts\/stromal cells","volume":"247","author":"Jimi","year":"1999","journal-title":"Exp. Cell Res."},{"issue":"2","key":"10.1016\/j.bcp.2019.02.020_b0325","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1210\/endo.136.2.7835314","article-title":"Macrophage colony-stimulating factor and interleukin-1 \u03b1 maintain the survival of osteoclast-like cells","volume":"136","author":"Jimi","year":"1995","journal-title":"Endocrinology"},{"issue":"8","key":"10.1016\/j.bcp.2019.02.020_b0330","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1002\/j.1460-2075.1990.tb07419.x","article-title":"Molecular cloning and expression of glycogen synthase kinase-3\/factor A","volume":"9","author":"Woodgett","year":"1990","journal-title":"EMBO J."},{"issue":"5","key":"10.1016\/j.bcp.2019.02.020_b0335","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1046\/j.1471-4159.2002.00918.x","article-title":"Alternative splicing isoform of tau protein kinase I\/glycogen synthase kinase 3\u03b2","volume":"81","author":"Mukai","year":"2002","journal-title":"J. Neurochem."},{"issue":"9","key":"10.1016\/j.bcp.2019.02.020_b0340","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.tips.2004.07.006","article-title":"Pharmacological inhibitors of glycogen synthase kinase 3","volume":"25","author":"Meijer","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bcp.2019.02.020_b0345","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3389\/fnmol.2011.00040","article-title":"GSK-3: functional insights from cell biology and animal models","volume":"4","author":"Kaidanovich-Beilin","year":"2011","journal-title":"Front. Mol. Neurosci."},{"issue":"6","key":"10.1016\/j.bcp.2019.02.020_b0350","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.devcel.2007.04.001","article-title":"Functional redundancy of GSK-3\u03b1 and GSK-3\u03b2 in Wnt\/\u03b2-catenin signaling shown by using an allelic series of embryonic stem cell lines","volume":"12","author":"Doble","year":"2007","journal-title":"Dev. Cell"},{"issue":"16","key":"10.1016\/j.bcp.2019.02.020_b0355","doi-asserted-by":"crossref","first-page":"8455","DOI":"10.1073\/pnas.93.16.8455","article-title":"A molecular mechanism for the effect of lithium on development","volume":"93","author":"Klein","year":"1996","journal-title":"Pro. Natl. Acad. Sci. U.S.A."},{"issue":"9","key":"10.1016\/j.bcp.2019.02.020_b0360","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0165-6147(02)02071-0","article-title":"Pharmacological inhibitors of cyclin-dependent kinases","volume":"23","author":"Knockaert","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"issue":"11","key":"10.1016\/j.bcp.2019.02.020_b0365","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ni1254","article-title":"Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages","volume":"6","author":"Harrington","year":"2005","journal-title":"Nat. Immunol."},{"issue":"8","key":"10.1016\/j.bcp.2019.02.020_b0370","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.4049\/jimmunol.178.8.4901","article-title":"Stat3 and Stat4 direct development of IL-17-secreting Th cells","volume":"178","author":"Mathur","year":"2007","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.bcp.2019.02.020_b0375","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.4049\/jimmunol.1003511","article-title":"Glycogen synthase kinase-3 is an early determinant in the differentiation of pathogenic Th17 cells","volume":"186","author":"Beurel","year":"2011","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.bcp.2019.02.020_b0380","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1002\/mc.22685","article-title":"Inhibition of glycogen synthase kinase 3 \u03b2 (GSK3\u03b2) suppresses the progression of esophageal squamous cell carcinoma by modifying STAT3 activity","volume":"56","author":"Gao","year":"2017","journal-title":"Mol. Carcinog."},{"issue":"5","key":"10.1016\/j.bcp.2019.02.020_b0385","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1161\/ATVBAHA.115.305438","article-title":"Deletion of myeloid GSK3\u03b1 attenuates atherosclerosis and promotes an M2 macrophage phenotype","volume":"35","author":"McAlpine","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"8","key":"10.1016\/j.bcp.2019.02.020_b0390","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1096\/fj.14-251900","article-title":"TNF-\u03b1 expression in neutrophils and its regulation by glycogen synthase kinase-3: a potentiating role for lithium","volume":"28","author":"Giambelluca","year":"2014","journal-title":"FASEB J."},{"issue":"6791","key":"10.1016\/j.bcp.2019.02.020_b0395","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/35017574","article-title":"Requirement for glycogen synthase kinase-3\u03b2 in cell survival and NF-\u03baB activation","volume":"406","author":"Hoeflich","year":"2000","journal-title":"Nature"},{"issue":"Pt 7","key":"10.1016\/j.bcp.2019.02.020_b0400","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1242\/jcs.00384","article-title":"GSK-3: tricks of the trade for a multi-tasking kinase","volume":"116","author":"Doble","year":"2003","journal-title":"J. Cell Sci."},{"issue":"6","key":"10.1016\/j.bcp.2019.02.020_b0405","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1002\/jcb.22881","article-title":"Glycogen synthase kinase-3\u03b2 indirectly facilitates interferon-gamma-induced nuclear factor-\u03baB activation and nitric oxide biosynthesis","volume":"111","author":"Kai","year":"2010","journal-title":"J. Cell. Biochem."},{"issue":"8","key":"10.1016\/j.bcp.2019.02.020_b0410","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/ni1221","article-title":"Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3","volume":"6","author":"Martin","year":"2005","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.bcp.2019.02.020_b0415","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jbspin.2013.09.006","article-title":"Inhibition of glycogen synthase kinase-3beta suppresses inflammatory responses in rheumatoid arthritis fibroblast-like synoviocytes and collagen-induced arthritis","volume":"81","author":"Kwon","year":"2014","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.bcp.2019.02.020_b0420","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.12659\/MSM.897739","article-title":"Inhibition of GSK-3\u03b2 alleviates collagen ii-induced rheumatoid arthritis in rats","volume":"22","author":"Zhou","year":"2016","journal-title":"Med. Sci. Monit."},{"issue":"1","key":"10.1016\/j.bcp.2019.02.020_b0425","doi-asserted-by":"crossref","first-page":"547","DOI":"10.4049\/jimmunol.182.1.547","article-title":"Toll-like receptor-mediated production of IL-1Ra is negatively regulated by GSK3 via the MAPK ERK1\/2","volume":"182","author":"Rehani","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.bcp.2019.02.020_b0430","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1742-2094-9-2","article-title":"Pharmacological inhibition of Akt and downstream pathways modulates the expression of COX-2 and mPGES-1 in activated microglia","volume":"9","author":"de Oliveira","year":"2012","journal-title":"J Neuroinflamm."},{"key":"10.1016\/j.bcp.2019.02.020_b0435","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.bcp.2016.07.014","article-title":"Inhibition of GSK-3 reduces prostaglandin E2 production by decreasing the expression levels of COX-2 and mPGES-1 in monocyte\/macrophage lineage cells","volume":"116","author":"Noma","year":"2016","journal-title":"Biochem. Pharmacol."},{"issue":"4","key":"10.1016\/j.bcp.2019.02.020_b0440","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.bcp.2014.06.011","article-title":"Acceleration of bone regeneration by local application of lithium: Wnt signal-mediated osteoblastogenesis and Wnt signal-independent suppression of osteoclastogenesis","volume":"90","author":"Arioka","year":"2014","journal-title":"Biochem. Pharmacol."},{"issue":"5","key":"10.1016\/j.bcp.2019.02.020_b0445","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1002\/jbmr.2147","article-title":"Indirubin-3'-oxime reverses bone loss in ovariectomized and hindlimb-unloaded mice via activation of the Wnt\/beta-catenin signaling","volume":"29","author":"Zahoor","year":"2014","journal-title":"J. Bone Miner. Res."},{"issue":"7","key":"10.1016\/j.bcp.2019.02.020_b0450","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1084\/jem.20040518","article-title":"RANKL-induced DC-STAMP is essential for osteoclastogenesis","volume":"200","author":"Kukita","year":"2004","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.bcp.2019.02.020_b0455","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1172\/JCI28551","article-title":"Regulation of bone mass by Wnt signaling","volume":"116","author":"Krishnan","year":"2006","journal-title":"J. Clin. Investig."},{"issue":"45","key":"10.1016\/j.bcp.2019.02.020_b0460","doi-asserted-by":"crossref","first-page":"39043","DOI":"10.1074\/jbc.M111.256768","article-title":"Inactivation of glycogen synthase kinase-3\u03b2 is required for osteoclast differentiation","volume":"286","author":"Jang","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2019.02.020_b0465","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.bone.2011.11.007","article-title":"GSK-3 inhibition by an orally active small molecule increases bone mass in rats","volume":"50","author":"Marsell","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.bcp.2019.02.020_b0470","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.gene.2004.06.044","article-title":"Wnt signaling in osteoblasts and bone diseases","volume":"341","author":"Westendorf","year":"2004","journal-title":"Gene"},{"issue":"10","key":"10.1016\/j.bcp.2019.02.020_b0475","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1359\/jbmr.2003.18.10.1842","article-title":"BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop","volume":"18","author":"Rawadi","year":"2003","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bcp.2019.02.020_b0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2013.09.126","article-title":"Acceleration of bone development and regeneration through the Wnt\/beta-catenin signaling pathway in mice heterozygously deficient for GSK-3\u03b2","author":"Arioka","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"9","key":"10.1016\/j.bcp.2019.02.020_b0485","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0000837","article-title":"GSK-3\u03b2 controls osteogenesis through regulating Runx2 activity","volume":"2","author":"Kugimiya","year":"2007","journal-title":"PLoS ONE"},{"issue":"11","key":"10.1016\/j.bcp.2019.02.020_b0490","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143865","article-title":"Lithium chloride dependent glycogen synthase kinase 3 inactivation links oxidative DNA damage, hypertrophy and senescence in human articular chondrocytes and reproduces chondrocyte phenotype of obese osteoarthritis patients","volume":"10","author":"Guidotti","year":"2015","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.bcp.2019.02.020_b0495","doi-asserted-by":"crossref","first-page":"12059","DOI":"10.1038\/s41598-017-12129-5","article-title":"Glycogen synthase kinase-3\u03b2 inhibition links mitochondrial dysfunction, extracellular matrix remodelling and terminal differentiation in chondrocytes","volume":"7","author":"Guidotti","year":"2017","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.bcp.2019.02.020_b0500","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1016\/j.cellsig.2013.04.002","article-title":"Wnt signaling pathway in rheumatoid arthritis, with special emphasis on the different roles in synovial inflammation and bone remodeling","volume":"25","author":"Miao","year":"2013","journal-title":"Cell. Signal."},{"issue":"11","key":"10.1016\/j.bcp.2019.02.020_b0505","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1002\/art.38799","article-title":"Dkk-1-mediated inhibition of Wnt signaling in bone ameliorates osteoarthritis in mice","volume":"66","author":"Funck-Brentano","year":"2014","journal-title":"Arthritis Rheumatol."},{"issue":"8","key":"10.1016\/j.bcp.2019.02.020_b0510","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1002\/art.38681","article-title":"Glycogen synthase kinase 3 inhibition stimulates human cartilage destruction and exacerbates murine osteoarthritis","volume":"66","author":"Litherland","year":"2014","journal-title":"Arthritis Rheumatol."},{"issue":"4","key":"10.1016\/j.bcp.2019.02.020_b0515","doi-asserted-by":"crossref","first-page":"571","DOI":"10.7150\/thno.14334","article-title":"Glycogen synthase kinase-3 (GSK-3)-targeted therapy and imaging","volume":"6","author":"Pandey","year":"2016","journal-title":"Theranostics"},{"issue":"7","key":"10.1016\/j.bcp.2019.02.020_b0520","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1136\/annrheumdis-2017-212647","article-title":"Hypermetabolic macrophages in rheumatoid arthritis and coronary artery disease due to glycogen synthase kinase 3\u03b2 inactivation","volume":"77","author":"Zeisbrich","year":"2018","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.bcp.2019.02.020_b0525","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41584-018-0148-8","article-title":"Cell metabolism as a potentially targetable pathway in RA","volume":"15","author":"McGarry","year":"2019","journal-title":"Nat. Rev. Rheumatol."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295219300589?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295219300589?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T15:05:08Z","timestamp":1762095908000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295219300589"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":105,"alternative-id":["S0006295219300589"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2019.02.020","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glycogen synthase kinase-3 inhibitor as a multi-targeting anti-rheumatoid drug","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2019.02.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}